P468: Evaluation of work productivity and activity impairment in moderate-to-severe ulcerative colitis participants treated with ozanimod in the phase 3 True North studyECCO'22Year: 2022
Authors: Floden, L.(1);Pham, T.P.(2);Kumar, J.(3);Becker, B.(3);Shaw, J.W.(3);Tencer, T.(3);
(1)Clinical Outcomes Solutions, Biostatistics, Chicago, United States;(2)Clinical Outcomes Solutions, Research, Chicago, United States;(3)Bristol Myers Squibb, Department of Immunology and Fibrosis Development, Princeton, United States;
P469: Infliximab for induction of medically-induced remission in Crohn's disease: a Cochrane systematic reviewECCO'22Year: 2022
Authors: Radford, S.(1);Sinopoulou, V.(2);Gordon, M.(2);Eldragini, M.E.A.A.(1);Darie, A.M.(1);Akobeng, A.(3);Moran, G.W.(1);
(1)Nottingham University Hospitals NHS Trust, NIHR Nottingham Biomedical Research Centre - Gastrointestinal and Liver disorders theme, Nottingham, United Kingdom;(2)UCLan, School of Medicine, Preston, United Kingdom;(3)Sidra Medicine, Medicine, Doha, Qatar;
P470: Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in BrazilECCO'22Year: 2022
Authors: Galhardi Gasparini, R.(1);Yukie Sassaki, L.(2);Lima Martins, A.(3);Saad Hossne, R.(4);Watanabe de Oliveira, R.(5);Yang Santos, C.(6);Biatti Barreto, T.(7);
(1)SETE – Specialized Medical Center, Gastroenterology Department, Marília - SP, Brazil;(2)Sao Paulo State University - UNESP- Medical School, Gastroenterology Department, Botucatu - SP, Brazil;(3)Espirito Santos Federal University - UFES, Gastroenterology Department, Vitoria - ES, Brazil;(4)Sao Paulo State University - UNESP- Medical School, Surgery Department, Botucatu - SP, Brazil;(5)IQVIA, Real-World Insights, Sao Paulo - SP, Brazil;(6)Takeda Pharmaceuticals, Clinical Research, Sao Paulo - SP, Brazil;(7)Takeda Pharmaceuticals, Medical Affairs, Sao Paulo - SP, Brazil;
P472: Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysisECCO'22Year: 2022
Authors: Le Cosquer, G.(1);Capirchio, L.(2);Rivière, P.(1);de Suray, N.(2);Poullenot, F.(1);De Vroey, B.(2);Berger, A.(1);Denis, M.A.(2);Zerbib, F.(1);Bachmann, R.(3);Remue, C.(3);Celerier, B.(4);Leonard, D.(3);Denost, Q.(4);Kartheuser, A.(3);Laharie, D.(1);Dewit, O.(2);
(1)Centre Hospitalo-Universitaire of Bordeaux- Hôpital Haut-Lévêque – University of Bordeaux, Hepato-gastroenterology and digestive oncology, Bordeaux, France;(2)Cliniques Universitaires Saint-Luc – Catholic University of Louvain, Hepato-gastroenterology, Brussels, Belgium;(3)Cliniques Universitaires Saint-Luc – Catholic University of Louvain, Colorectal surgery, Brussels, Belgium;(4)Centre Hospitalo-Universitaire of Bordeaux- Hôpital Haut-Lévêque – University of Bordeaux, Digestive and endocrine surgery, Bordeaux, France;
P473: Real world experience with the Crohn's Disease Exclusion Diet (CDED) in a tertiary IBD clinicECCO'22Year: 2022
Authors: Fliss Isakov, N.(1);Anbar, R.(2);Cooperstein, A.(2);Helbert, G.(2);Hirsch, A.(1);Ron, Y.(1);Thurm, T.(1);Maharshak, N.(1);
(1)Tel Aviv Sourasky Medical Center, Department of Gastroenterology and Liver Diseases- Sackler Faculty of Medicine, Tel Aviv, Israel;(2)Tel Aviv Sourasky Medical Center, Nutrition and dietetics department, Tel Aviv, Israel;
P474: Prevalence of fecal incontinence and clinical characteristics of IBD patients in remission and treated with biologics – experience from a tertiary referral centerECCO'22Year: 2022
Authors: Jelakovic, M.(1);Turk, N.(1);Brinar, M.(1);Barisic, A.(1);Grgic, D.(1);Cukovic-Cavka, S.(1);Krznaric, Z.(1);
(1)KBC Zagreb, Department of Gastroenterology and Hepatology, Zagreb, Croatia;
P475: Profiling the use of Complementary Alternative Medicines among IBD patientsECCO'22Year: 2022
Authors: Sudhakar, P.(1);Stiers, R.(1);Dycker, E.D.(2);Geens, P.(2);Paps, A.(2);Lambrechts, T.(2);Keersmaekers, B.(2);Sabino, J.(1,3);Ferrante, M.(1,3);Vermeire, S.(1,3);Verstockt, B.(1,3);
(1)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing- Translational Research Center for Gastrointestinal Disorders TARGID, Leuven, Belgium;(2)University Hospital Leuven, IBD Leuven, Leuven, Belgium;(3)University Hospital Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
P477: Rectal bleeding and stool frequency improvement with tofacitinib retreatment in patients with Ulcerative Colitis after treatment interruption: Results from OCTAVE OpenECCO'22Year: 2022
Authors: Allegretti, J.R.(1);Gecse, K.B.(2);Chiorean, M.V.(3);Argollo, M.(4);Guo, X.(5);Lawendy, N.(5);Su, C.(5);Mundayat, R.(6);Paulissen, J.(6);Salese, L.(5);Irving, P.M.(7);
(1)Brigham and Women's Hospital, Division of Gastroenterology- Hepatology and Endoscopy, Boston- MA, United States;(2)Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(3)-, Swedish Medical Center, Seattle- WA, United States;(4)Federal University of São Paulo, Department of Gastroenterology, São Paulo, Brazil;(5)-, Pfizer Inc, Collegeville- PA, United States;(6)-, Pfizer Inc, New York- NY, United States;(7)Guy’s and St Thomas’ Hospital, IBD Unit, London, United Kingdom;
P478: The role of proactive measurement of adalimumab trough levels and antibodies to adalimumab in Greek patients with Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Orfanoudaki, E.(1);Gazouli, M.(2);Theodoraki, E.(1);Foteinogiannopoulou, K.(1);Andreou, N.P.(2);Koutroubakis, I.E.(1);
(1)University Hospital of Heraklion- Medical School- University of Crete, Gastroenterology, Heraklion Crete, Greece;(2)Medical School- National and Kapodistrian University of Athens- Greece, Department of Basic Medical Sciences- Laboratory of Biology, Athens, Greece;
P480: Comparison of executive functioning profiles among adults with Crohn's disease and Ulcerative colitisECCO'22Year: 2022
Authors: Zelnik Yovel, D.(1);Meyer, S.(2);Richter, V.(1);Shirin, H.(1);Broide, E.(1);
(1)Shamir Medical center, Gastroenterology, Zerifin, Israel;(2)Ariel University, Faculty of Health Sciences, Ariel, Israel;
P481: profile of elderly patients in which biological drugs are used for the treatment of inflammatory bowel diseaseECCO'22Year: 2022
Authors: Suarez Ferrer, C.J.(1);Mesonero, F.(2);Caballol, B.(3);Ballester, M.P.(4);Baston Rey, I.(5);Castaño Garcia, A.(6);MIranda Bautista, J.(7);Saiz Chumillas, R.(8);Benitez, J.M.(9);Sanchez Delgado, L.(10);Lopez-Garcia, A.(11);Rubin de Celio, C.(12);Alonso Abreu, I.(13);Melcarne, L.(14);Plaza Santos, R.(15);Marques Cami, M.(16);Caballero Mateos, A.(17);Gomez Diez, C.(18);Calafat, M.(19);Alonso Galan, H.(20);Vega Vilaamil, P.(21);Castro Sensosian, B.(22);Guerro Moya, A.(23);Rodriguez Diaz, C.Y.(24);Spicakova, K.(25);Manceñido Marcos, N.(26);Molina, G.(27);De Castro, L.(28);Rodriguez Angulo , A.(29);Cuevas del Campo , L.(30);Rodriguez Grau, M.C.(31);Ramirez, F.(32);Gomez Pastrana, B.(33);Gonzalez Partida, I.(34);Botella Mateu, B.(35);Peña Gonzalez, E.(36);Iyo, E.(37);Elosua Gonzalez , A.(38);Mañosa Ciria, M.(39);Barreiro-De Acosta, M.(40);
(1)Hospital Universitario La Paz, Gastroenterology department. IBD Unit., Madrid, Spain;(2)Hospital Universitario Ramon y Cajal, Gastroenterology Department, Madrid, Spain;(3)Hospital Clinic Barcelona, Gastroenterology, Barcelona, Spain;(4)Hospital Clinic de Valencia, Gastroenterology, Valencia, Spain;(5)Hospital universitario clinico de santiago, Gastroenterology, Santiago de Compostela, Spain;(6)Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain;(7)Hospital Gregorio Marañon, Gastroenterology, Madrid, Spain;(8)Hospital Universitario Burgos, Gastroenterology, Burgos, Spain;(9)Hospital Reina Sofia, Gastroenterology, Cordoba, Spain;(10)Hospital universitario Valladolid, Gastroenterology, Valladolid, Spain;(11)Hospital del Mar, Gastroenterology, Barcelona, Spain;(12)Hospital universitario La Princesa, Gastroenterology, Madrid, Spain;(13)Hospital universitario de Canarias, Gastroenterology, Santa Cruz de Tenerife, Spain;(14)Hospital Universitario Parc Taulli Sabadel, Gastroenterology, Barcelona, Spain;(15)Hospital Infanta Leonor, Gastroenterology, Madrid, Spain;(16)Hospital Arnau de Vilanova, Gastroenterology, Lleida, Spain;(17)Hospital Clinic San Cecilio, Gastroenterology, Granada, Spain;(18)Hospital Universitario Cabueñes, Gastroenterology, Gijon, Spain;(19)Hospital Germans Trias i Pujol, Gastroenterology, Badalona, Spain;(20)Hospital universitario de Donostia, Gastroenterology, San Sebastian, Spain;(21)Complexo Hospitalario Universitario de Ourense, Gastroenterologia, Ourense, Spain;(22)Hospital Universitario Marqués de Valdecilla. IDIVAL, Gastroenterology, Santander, Spain;(23)Complexo Hospitalario Universitario A Coruña, Gastroenterology, Coruña, Spain;(24)Hospital Universitario Nuestra Señora de la Candelaria, Gastroenterology, Tenerife, Spain;(25)Hospital Universitario de Alava, Gastroenterology, Vitoria, Spain;(26)Hospital Infanta Sofia, Gastroenterology, Madrid, Spain;(27)Hospital Universitario de Ferrol, Gastroenterology, Coruña, Spain;(28)Hospital Universitario Álvaro Cunqueiro, Gastroenterology, Vigo, Spain;(29)Hospital Universitario de Alicante, Gastroenterology, Alicante, Spain;(30)Getafe University Hospital, Gastroenterology, Madrid, Spain;(31)Hospital del Henares-Coslada, Gastroenterology, Madrid, Spain;(32)Ciudad Real University Hospital, Gastroenterology, Ciudad Real, Spain;(33)General Hospital of Mataro- Maresme-Barcelona, Gastroenterology, Barcelona, Spain;(34)Puerta de Hierro University Hospital. Majadahonda, Gastroenterology, Madrid, Spain;(35)Hospital Univesitario Infanta Cristina-Parla, Gastroenterology, Madrid, Spain;(36)Hospital Royo Villanova, Gastroenterology, Zaragoza, Spain;(37)Hospital Comarcal de Inca, Gastroenterology, Baleares, Spain;(38)Hospital Garcia Orcoyen- Estella, Gastroenterology, Navarra, Spain;(39)Hospital Germans Trias i Pujol-, Gastroenterology, Badalona., Spain;(40)Hospital Universitario Clínico de Santiago, Gastroenterology, Santiago de Compostela, Spain;on behalf of the Young Group of GETECCU
P482: Pre-screening IBD patients starting biologic therapies, a positive single centre quality improvement projectECCO'22Year: 2022
Authors: Colclough, J.(1);Ali, M.(2);Shami, N.(2);Aitchison, L.(2);Hurst, A.(2);Shams-Khan, H.(2);
(1)Wirral University Teaching Hospital, Gastroenterology, Liverpool, United Kingdom;(2)Southport and Ormskirk NHS trust, Gastroenterology, Soutport, United Kingdom;
P483: Patient-reported quality of life, anxiety, and depression associated with switching originator infliximab to biosimilarECCO'22Year: 2022
Authors: Ritter, T.E.(1);Mehta, S.A.(2);Van Anglen, L.J.(2);
(1)GI Alliance, Research and Education, Southlake- TX, United States;(2)Healix Infusion Therapy, Clinical Research, Sugar Land- TX, United States;
P484: Do vedolizumab trough levels predict response to consecutive therapy in Inflammatory Bowel Disease?ECCO'22Year: 2022
Authors: Levartovsky, A.(1);Cohen, I.(1);Abitbol, C.M.(1);Yavzori, M.(1);Fudim, E.(1);Picard, O.(1);Kopylov, U.(1);Ben-Horin, S.(1);Ungar, B.(1);
(1)Sheba Medical center, Department of Gastroenterology, Tel Hashomer, Israel;
P485: Apolipoprotein C3 is Downregulated in Patients with Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Hernandez Camba, A.(1);Carrillo Palau, M.(2);Ramos, L.(2);Alonso, I.(2);Vela, M.(1);Hernández, A.(2);Arranz , L.(1);Hernández, N.(2);Hernández-Guerra, M.(2);Ferráz, I.(3);
(1)Hosp. Universitario Nuestra Señora de la Candelaria, Department of Gastroenterology, Santa Cruz de Tenerife, Spain;(2)Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain;(3)Hospital Universitario de Canarias, Reumatology, La Laguna, Spain;ATEROEII
P486: Treatment-emergent COVID-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trialsECCO'22Year: 2022
Authors: Ungaro , R.(1);Siegel , C.A.(2);Cree , B.A.C.(3);Selmaj , K.W.(4,6);Ahmad , H.A.(5);Pai , A.(5);Ather , S.(5);Henry , A.(5);Charles , L.(5);Petersen , A.(5);Cheng , C.Y.(5);Afsari , S.(5);Sheffield , J.(5);Vaile , J.(5);Colombel , J.F.(1);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(2)Dartmouth-Hitchcock Medical Center, Gastroenterology, Lebanon, United States;(3)UCSF MS Center, Neurology, San Francisco, United States;(4)Centrum of Neurology, n/a, Lodz, Poland;(5)Bristol Myers Squibb, Department of Immunology and Fibrosis Development, Princeton, United States;(6)University of Warmia & Mazury, Department of Neurology, Olsztyn, Poland;
P487: Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes (SCAR Study)ECCO'22Year: 2022
Authors: Chaparro, M.(1);Aguas, M.(2);Livne, M.(3);Rivière, P.(4);Bar-Gil Shitrit, A.(5);Myrelid, P.(6);Arroyo, M.(7);Barreiro-de Acosta, M.(8);Bautista, M.(9);Biancone, L.(10);Biron, I.A.(5);Boysen, T.(11);Carpio, D.(12);Castro, B.(13);Dragoni, G.(14);Ellul, P.(15);Holubar, S.D.(16);de Jorge, M.Á.(17);Leo, E.(18);Manceñido, N.(19);Moens, A.(20);Ramírez de la Piscina, P.(21);Ricanek, P.(22);Sebkona, L.(23);Sempere, L.(24);Teich, N.(25);Gisbert, J.P.(1);Julsgaard, M.(26);
(1)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid- and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Unit, Madrid, Spain;(2)Hospital Universitario y Politécnico La Fe and CIBERehd, Gastroenterology Unit, Valencia, Spain;(3)Sheba Medical Center, Gastroenterology Unit, Tel Hashomer, Israel;(4)Bordeaux University Hospitals, Gastroenterology Unit, Bordeaux, France;(5)Shaare Zedek Medical Center, Gastroenterology Unit, Jerusalem, Israel;(6)Linköping University Hospital and Department of Biomedical and Clinical Sciences- Linköping University, Surgery, Linköping, Sweden;(7)Hospital Clínico Universitario Lozano Blesa- CIBERehd and IIS Aragón, Gastroenterology Unit, Zaragoza, Spain;(8)Complejo Hospitalario Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain;(9)Hospital Joan XXIII, Gastroenterology Unit, Tarragona, Spain;(10)University of Rome “Tor Vergata”, Gastroenterology Unit, Rome, Italy;(11)Hvidovre University Hospital, Gastroenterology Unit, Hvidovre, Denmark;(12)Complexo Hospitalario Universitario de Pontevedra- Instituto de Investigación Sanitaria Galicia Sur, Gastroenterology Unit, Pontevedra, Spain;(13)Hospital Universitario Marqués de Valdecilla and IDIVAL, Gastroenterology Unit, Santander, Spain;(14)Careggi University Hospital, Gastroenterology Unit, Florence, Italy;(15)Mater Dei Hospital, Gastroenterology Unit, Msida, Malta;(16)Cleveland Clinic Foundation, Gastroenterology Unit, Cleveland, United States;(17)Hospital de Cabueñes, Gastroenterology Unit, Gijón, Spain;(18)Hospital Universitario Virgen del Rocío, Gastroenterology Unit, Sevilla, Spain;(19)Hospital Universitario Infanta Sofía, Gastroenterology Unit, San Sebastián de los Reyes, Spain;(20)University hospitals Leuven, Gastroenterology Unit, Leuven, Belgium;(21)Hospital Universitario de Araba sede Txagorritxu y sede Santiago, Gastroenterology Unit, Álava, Spain;(22)Akershus universitetssykehus, Gastroenterology Unit, Ski, Norway;(23)Azieda Opedaliera Pluguiese-Ciaccio, Gastroenterology Unit, Catanzaro, Italy;(24)Hospital General Universitario de Alicante and CIBERehd, Gastroenterology Unit, Alicante, Spain;(25)Practice for internal medicine, Gastroenterology Unit, Leipzig, Germany;(26)Aarhus University Hospital, Gastroenterology Unit, Aarhus, Denmark;on behalf of the ECCO CONFER taskforce
